Ultragenyx Pharmaceutical (RARE) Cash & Equivalents Growth (5y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.54% |
| Dec 31, 2025 | -10.01% |
| Sep 30, 2025 | 0.50% |
| Jun 30, 2025 | -12.08% |
| Mar 31, 2025 | -15.69% |
| Dec 31, 2024 | -16.69% |
| Sep 30, 2024 | 4.21% |
| Jun 30, 2024 | 29.63% |
| Mar 31, 2024 | -16.08% |
| Dec 31, 2023 | 13.54% |
| Sep 30, 2023 | -2.64% |
| Jun 30, 2023 | -1.64% |
| Mar 31, 2023 | -17.67% |
| Dec 31, 2022 | 5.76% |
| Sep 30, 2022 | 45.33% |
| Jun 30, 2022 | 11.99% |
| Mar 31, 2022 | -0.70% |
| Dec 31, 2021 | 13.81% |
| Sep 30, 2021 | 6.78% |
| Jun 30, 2021 | 39.50% |
| Mar 31, 2021 | 40.24% |
| Dec 31, 2020 | 50.13% |
| Sep 30, 2020 | 3.45% |
| Jun 30, 2020 | 45.01% |
| Mar 31, 2020 | 10.87% |
| Dec 31, 2019 | 77.91% |
| Sep 30, 2019 | 18.08% |
| Jun 30, 2019 | 49.73% |
| Mar 31, 2019 | 37.22% |
| Dec 31, 2018 | 72.50% |
| Sep 30, 2018 | 68.82% |
| Jun 30, 2018 | 52.35% |
| Mar 31, 2018 | 28.47% |